Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROCTER & GAMBLE Co Director's Dealing 2023

Apr 25, 2023

29757_dirs_2023-04-25_bd5be6e5-92eb-475c-90b3-8bb0c6ed3894.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROCTER & GAMBLE Co (PG)
CIK: 0000080424
Period of Report: 2023-04-24

Reporting Person: Davis Jennifer L. (CEO - Health Care)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-04-24 Common Stock M 23943 $78.52 Acquired 63803.3494 Direct
2023-04-24 Common Stock S 23943 $155.27 Disposed 39860.3494 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-15 Restricted Stock Units $ A 13.1852 Acquired Common Stock (13.1852) Direct
2023-04-24 Stock Option (Right to Buy) $78.52 M 23943 Disposed 2028-02-28 Common Stock (23943) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 13164.1185 Indirect

Footnotes

F1: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.

F2: Reflects adjustment to PST through March 31, 2023.

F3: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F4: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.